Real-time surgical ultrasound firm Tissue Differentiation Intelligence (TDI) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its SonoVision ultrasound platform.
The SonoVision scanner from Tissue Differentiation Intelligence (TDI). Image courtesy of TDI.SonoVision is designed for intraoperative access to the spine by using color to intuitively differentiate nerves, muscle, and bone. The technology applies layers of image-processing algorithms to acquire ultrasound images in real-time.
The company currently has several systems contributing to data collection for alpha evaluations focused primarily on the clinical refinement of the lateral surgery access product. Expanded procedural applications, including posterior access to the spine, 3D imaging, and image-guided navigation integration also are in the early stages of procedural development.
